dantrolene has been researched along with Pleural Effusion in 11 studies
Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.
Pleural Effusion: Presence of fluid in the pleural cavity resulting from excessive transudation or exudation from the pleural surfaces. It is a sign of disease and not a diagnosis in itself.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To describe a new case of eosinophilic pleural effusion induced by dantrolene chronic administration." | 8.82 | Dantrolene and pleural effusion: case report and review of literature. ( Calmels, P; Fayolle-Minon, I; Gautheron, V; Lê-Quang, B; Valayer-Chaléat, E, 2004) |
| "Twelve years after the initiation of low-dose dantrolene therapy for chronic spasticity, a 35-year-old man developed a pleural effusion with pleural and peripheral eosinophilia." | 8.79 | Pleural effusion associated with chronic dantrolene administration. ( Bachtel, MD; Mahoney, JM, 1994) |
| " He had been treated for spastic paraplegia with dantrolene sodium for 28 months." | 7.71 | [Eosinophilic pleural effusion associated with dantrolene administration]. ( Asada, K; Chida, K; Inui, N; Kuwata, H; Matsuda, H; Miwa, S; Nakamura, H; Nakamura, Y; Nakano, H; Shirai, T; Suda, T; Suzuki, K; Yokomura, K, 2002) |
| "A patient developed pulmonary infiltration, pleural effusions and pericarditis three months after starting dantrolene sodium." | 7.67 | Pneumonitis, pleural effusion and pericarditis following treatment with dantrolene. ( Haas, LF; Miller, DH, 1984) |
| "A quadriplegic patient with severe spasticity, treated with dantrolene (400 mg daily) for 5 years, had dyspnea, orthopnea, hypoxia, and right-sided opacity of the chest on radiograph." | 5.31 | Eosinophilic pleural effusion due to dantrolene: resolution with steroid therapy. ( Felz, MW; Haviland-Foley, DJ, 2001) |
| "To describe a new case of eosinophilic pleural effusion induced by dantrolene chronic administration." | 4.82 | Dantrolene and pleural effusion: case report and review of literature. ( Calmels, P; Fayolle-Minon, I; Gautheron, V; Lê-Quang, B; Valayer-Chaléat, E, 2004) |
| "Twelve years after the initiation of low-dose dantrolene therapy for chronic spasticity, a 35-year-old man developed a pleural effusion with pleural and peripheral eosinophilia." | 4.79 | Pleural effusion associated with chronic dantrolene administration. ( Bachtel, MD; Mahoney, JM, 1994) |
| " He had been treated for spastic paraplegia with dantrolene sodium for 28 months." | 3.71 | [Eosinophilic pleural effusion associated with dantrolene administration]. ( Asada, K; Chida, K; Inui, N; Kuwata, H; Matsuda, H; Miwa, S; Nakamura, H; Nakamura, Y; Nakano, H; Shirai, T; Suda, T; Suzuki, K; Yokomura, K, 2002) |
| "A patient developed pulmonary infiltration, pleural effusions and pericarditis three months after starting dantrolene sodium." | 3.67 | Pneumonitis, pleural effusion and pericarditis following treatment with dantrolene. ( Haas, LF; Miller, DH, 1984) |
| "The pleural effusions are typically chronic and somewhat torpid, most often bilateral but may be unilateral." | 2.39 | [Drug-induced pleurisy]. ( Benard, A; Guenanen, H; Tillie-Leblond, I; Wallaert, B, 1996) |
| "A quadriplegic patient with severe spasticity, treated with dantrolene (400 mg daily) for 5 years, had dyspnea, orthopnea, hypoxia, and right-sided opacity of the chest on radiograph." | 1.31 | Eosinophilic pleural effusion due to dantrolene: resolution with steroid therapy. ( Felz, MW; Haviland-Foley, DJ, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alagha, K | 1 |
| Tummino, C | 1 |
| Sofalvi, T | 1 |
| Chanez, P | 1 |
| Krenke, R | 1 |
| Light, RW | 1 |
| Yokomura, K | 1 |
| Chida, K | 1 |
| Suda, T | 1 |
| Miwa, S | 1 |
| Nakano, H | 1 |
| Kuwata, H | 1 |
| Suzuki, K | 2 |
| Matsuda, H | 1 |
| Asada, K | 1 |
| Nakamura, Y | 1 |
| Inui, N | 1 |
| Shirai, T | 1 |
| Nakamura, H | 1 |
| Lê-Quang, B | 1 |
| Calmels, P | 1 |
| Valayer-Chaléat, E | 1 |
| Fayolle-Minon, I | 1 |
| Gautheron, V | 1 |
| Okada, M | 1 |
| Nakagawa, E | 1 |
| Masuyama, T | 1 |
| Fujikawa, Y | 1 |
| Komaki, H | 1 |
| Sugai, K | 1 |
| Sasaki, M | 1 |
| Miller, DH | 1 |
| Haas, LF | 1 |
| Mahoney, JM | 1 |
| Bachtel, MD | 1 |
| Benard, A | 1 |
| Guenanen, H | 1 |
| Tillie-Leblond, I | 1 |
| Wallaert, B | 1 |
| Felz, MW | 1 |
| Haviland-Foley, DJ | 1 |
| Petusevsky, ML | 1 |
| Faling, LJ | 1 |
| Rocklin, RE | 1 |
| Snider, GL | 1 |
| Merliss, AD | 1 |
| Moses, JM | 1 |
| Dorman, SA | 1 |
| Sahn, SA | 1 |
6 reviews available for dantrolene and Pleural Effusion
| Article | Year |
|---|---|
Iatrogenic eosinophilic pleural effusion.
Topics: Adult; Benzodiazepines; Biopsy; Dantrolene; Eosinophilia; Humans; Iatrogenic Disease; Male; Middle A | 2011 |
Dantrolene and pleural effusion: case report and review of literature.
Topics: Dantrolene; Female; Humans; Middle Aged; Muscle Relaxants, Central; Muscle, Skeletal; Nitrofurantoin | 2004 |
[Pleural effusion associated with long-term dantrolene administration in three patients with severe motor and intellectual disabilities].
Topics: Adult; Dantrolene; Diagnosis, Differential; Disabled Persons; Eosinophilia; Female; Humans; Intellec | 2006 |
Pleural effusion associated with chronic dantrolene administration.
Topics: Adult; Dantrolene; Eosinophilia; Humans; Male; Pleural Effusion; Time Factors | 1994 |
[Drug-induced pleurisy].
Topics: Bromocriptine; Dantrolene; Dopamine Agonists; Ergotamines; Fibrosis; Humans; Muscle Relaxants, Centr | 1996 |
Immunologic diseases of the pleura.
Topics: Adult; Aged; Bromocriptine; Cardiac Surgical Procedures; Collagen Diseases; Dantrolene; Female; Gran | 1985 |
5 other studies available for dantrolene and Pleural Effusion
| Article | Year |
|---|---|
Drug-induced eosinophilic pleural effusion.
Topics: Benzodiazepines; Dantrolene; Eosinophilia; Humans; Iatrogenic Disease; Male; Muscle Relaxants, Centr | 2011 |
[Eosinophilic pleural effusion associated with dantrolene administration].
Topics: Adult; Dantrolene; Diagnosis, Differential; Eosinophilia; Humans; Male; Paraplegia; Pleural Effusion | 2002 |
Pneumonitis, pleural effusion and pericarditis following treatment with dantrolene.
Topics: Adult; Dantrolene; Female; Humans; Muscle Spasticity; Pericarditis; Pleural Effusion; Pneumonia; Rad | 1984 |
Eosinophilic pleural effusion due to dantrolene: resolution with steroid therapy.
Topics: Adult; Anti-Inflammatory Agents; Dantrolene; Drug Hypersensitivity; Eosinophilia; Humans; Male; Musc | 2001 |
Pleuropericardial reaction to treatment with dantrolene.
Topics: Acute Disease; Adult; Chronic Disease; Dantrolene; Female; Humans; Male; Middle Aged; Muscle Spastic | 1979 |